A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)

Clinical trial NCT01357148 · TERMINATED

Trial details

NCT number: NCT01357148
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2009-03-01
Primary completion: 2010-05-01
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.